Opportunities For unpartnered assets

December 16, 2016 Christoph Graener

Steven Muntner, vice president of deals at Informa Pharma Intelligence, discusses key takeaways from a recent report looking at pharma partnering and deal trends. On the sidelines of the 2016 BIO-Europe partnering meeting, he also highlights the biggest opportunities for unpartnered assets and recent changes in the partnering landscape.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Steven Muntner – VP/Head of Deals, Pharma Intelligence, Informa

Previous Article
Consumer products give new life to pharma
Consumer products give new life to pharma

The relevance of the consumer isn’t a new condition, but the role consumers play as companies make product ...

Next Article
AdAlta CEO on shark antibody technology

AdAlta is developing a novel technology platform that engineers the key stability features of the antigen b...